The natural active oligopeptide with
hepatoprotective and anti-liver fibrosis effect has a novel structure, precise efficacy, and high therapeutic index. The product can be widely used in the prevention, diagnosis, and treatment of tumors, hepatitis, diabetes, AIDS, and other diseases.
Oligopeptide
Our products have obtained the following patents:
U.S. patent name: an oligopeptide for treating liver fibrosis and/or treating hepatitis B and/or improving liver function.
Chinese patent name: Anti-HBV oligopeptide and its derivatives.
Plate-X Peptide
In peptide project, OC1 is a natural active heptapeptide derived from a
traditional Chinese medicine, which has strong anti-fibrotic activity and has a broad market development prospect. The main purpose of anti-liver fibrosis treatment is to prevent the occurrence of liver fibrosis (anti-liver injury), inhibit the formation of liver fibrosis (against HSC), and promote the degradation of liver fibrosis. The available information shows that heptapeptide OC1 can prevent and treat liver fibrosis by improving immunity, protecting normal liver cells, and killing liver fibrosis-related cells, with obvious efficacy and selective pharmacological activity; it has a good effect on acute and chronic liver injury caused by CCl4 and alcohol in vivo, especially on immune liver fibrosis caused by pig serum. The superior pharmacological activity indicates its potential to be the first clinical peptide drug against liver fibrosis.
Application of Peptides In Medicine
Improve drug efficacy and improve drug treatment effect.
Reduce the adverse reactions of drugs, especially western drugs.
Shorten the course of treatment.
Expand the scope of indications.